• Arachidonic Acid Supplementation Accelerates Humoral Immunit

  2026-06-11

  This study demonstrates that dietary arachidonic acid (ARA) supplementation dramatically accelerates and enhances vaccine-induced humoral immunity in both mice and humans. Mechanistic insights reveal that ARA-derived metabolites upregulate B cell activation via the cAMP-PKA pathway, providing a new avenue for designing vaccine adjuvants and immune modulation strategies.

• Methyl-β-cyclodextrin: Technical Use in Membrane Cholesterol

  2026-06-11

  Methyl-β-cyclodextrin provides a controlled means to selectively extract cholesterol and lipids from cellular membranes, supporting experiments in membrane organization, lipid raft disruption, and cholesterol-dependent signaling. It is not intended for diagnostic or therapeutic applications, and strict adherence to handling and storage guidelines is required to maintain reagent efficacy.

• Pepstatin A: Unveiling New Horizons in Aspartic Protease Inh

  2026-06-10

  Explore Pepstatin A as a gold-standard aspartic protease inhibitor, with a focus on protocol optimization and translational research applications. This article uniquely analyzes practical assay design considerations, bridging foundational mechanisms with the latest innovations.

• Applied Use of α-Linolenic Acid in Lipid Metabolism Research

  2026-06-10

  α-Linolenic Acid (ALA) unlocks precision in lipid metabolism, cardiovascular, and inflammation studies—empowering reproducible, high-impact protocols in both cellular and animal models. This guide translates recent mechanistic advances into actionable workflows, troubleshooting, and future outlook for advanced experimental research.

• Penicillin G Sodium: Precision Workflows for Gram-Positive C

  2026-06-09

  Penicillin G Sodium from APExBIO empowers researchers with high-fidelity, reproducible inhibition of Gram-positive bacteria. Discover advanced workflows, troubleshooting strategies, and practical protocol optimizations that set this natural penicillin antibiotic apart in experimental and translational research.

• ATRA Overcomes Cisplatin-Induced PARP Inhibitor Resistance i

  2026-06-09

  Mei et al. (2025) demonstrate that all-trans retinoic acid (ATRA) can restore sensitivity to PARP inhibition in epithelial ovarian cancer (EOC) cells that have acquired resistance following cisplatin exposure. This mechanistic insight suggests a practical strategy to improve maintenance therapy outcomes in EOC, including both BRCA-mutant and wild-type settings.

• Sisomicin in Antibacterial Research: Protocols, Advantages,

  2026-06-08

  Sisomicin, a potent aminoglycoside antibiotic, delivers robust inhibition of bacterial protein synthesis for both Gram-negative and Gram-positive infection models. This article details optimized experimental workflows, protocol parameters, and actionable troubleshooting strategies that distinguish Sisomicin’s utility in translational research.

• Protease Inhibitor Cocktail (EDTA-Free, 100X): Mechanisms &

  2026-06-08

  The Protease Inhibitor Cocktail (EDTA-Free, 100X in DMSO) preserves protein integrity during extraction by broadly inhibiting endogenous proteases. Its EDTA-free formulation is essential for workflows sensitive to divalent cations, such as phosphorylation analysis. APExBIO’s K1010 cocktail is validated across Western blot and immunoprecipitation protocols for reliable protease inhibition.

• Spliceosome Acetylation Regulates HCC Sensitivity to PARP In

  2026-06-07

  This study uncovers acetylation-dependent regulation of the spliceosomal protein SmD2 as a critical modulator of DNA damage repair and PARP inhibitor response in hepatocellular carcinoma (HCC). The findings highlight the therapeutic potential of targeting splicing machinery and acetylation pathways to sensitize HCC cells to PARP inhibition, broadening strategies for DNA repair-deficient cancer treatment.

• Blocking EV Release in Triple-Negative Breast Cancer: Calpep

  2026-06-06

  McNamee et al. systematically evaluated the capacity of several small molecules—including the calpain inhibitor Calpeptin—to suppress extracellular vesicle (EV) release from triple-negative breast cancer (TNBC) cells. Their findings reveal that robust inhibition of EVs, including with Calpeptin, can markedly reduce the transfer of aggressive cancer traits, providing a benchmark for mechanistic studies on tumor cell communication.

• Type III Collagen’s Tumor-Restrictive Role in Breast Cancer

  2026-06-05

  This study provides compelling evidence that type III collagen (Col3) in the breast cancer microenvironment exerts a tumor-restrictive effect, limiting cancer progression and metastasis. Analysis of patient samples, in vitro and in vivo models, and bioinformatics reveal that higher Col3 levels are associated with improved survival outcomes, suggesting new avenues for therapeutic strategies in breast cancer.

• Hematoxylin and Eosin Staining Kit: Protocol, QC, and Troubl

  2026-06-05

  The Hematoxylin and Eosin Staining Kit (SKU: K1142) streamlines tissue morphology visualization in research settings by providing ready-to-use solutions for consistent nuclear and cytoplasmic staining. It is ideal for histopathological and cytological assessment of paraffin-embedded, frozen, or cytology specimens, but is not intended for clinical diagnostics.

• Arachidonic Acid Supplementation Accelerates Humoral Immunit

  2026-06-04

  The referenced study demonstrates that dietary arachidonic acid (ARA) administration significantly enhances vaccine-induced humoral immunity by accelerating the production of protective neutralizing antibodies in both mice and humans. These findings offer new mechanistic insights into how ARA metabolites in lymph nodes modulate B cell activation, providing promising strategies for immune modulation and vaccine adjuvant research.

• Neticonazole Hydrochloride: Bridging Antifungal Action and C

  2026-06-04

  Explore the dual-action potential of Neticonazole Hydrochloride as a leading imidazole antifungal and anticancer agent. This in-depth review uniquely connects molecular mechanisms with translational strategies for colorectal cancer research.

• Blocking GCLC Truncation Delays Age-Related Cataract Formati

  2026-06-03

  Wei et al. (2024) demonstrate that preventing the age-related truncation of γ-glutamylcysteine ligase catalytic subunit (GCLC) preserves lens glutathione levels and substantially delays cataract onset in mice. This mechanistic insight establishes a causal link between GCLC truncation, glutathione depletion, and lens aging, offering a targetable pathway for non-surgical cataract prevention strategies.

460 records 9/31 page Previous Next First page 上5页 678910 下5页 Last page